Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

NCT06850805 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis Without Nasal Polyps

Interventions

DRUG: OPN-375
DRUG: Placebo

Sponsor

Optinose US Inc.